Attached files

file filename
EX-32.1 - CERTIFICATION - Mansfield-Martin Exploration Mining, Inc.ex32one.htm
EX-31.2 - CHIEF FINANCIAL OFFICER CERTIFICATION - Mansfield-Martin Exploration Mining, Inc.ex31two.htm
EX-31.1 - CHIEF EXECUTIVE OFFICER CERTIFICATION - Mansfield-Martin Exploration Mining, Inc.ex31one.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 10-Q/A

(Amendment No. 1)

 

(Mark One)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: June 30, 2015

 

or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission File Number: 333-173873

 

               Med-Cannabis Pharma, Inc.                      

 (Exact name of registrant as specified in its charter)

 

Nevada 45-0704149

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

 

817 NW Hill Street Bend, OR 97701

 (Address of principal executive offices)

 

  Tel: (214) 666-8364

 (Registrant’s telephone number, including area code)

 

NA 

 (Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports to be filed by Section 13 or Section 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):

 

Large Accelerated Filer Accelerated Filer  
Non-Accelerated Filer   Do not check if a smaller reporting company) Smaller Reporting Company  

  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes No x

 

The number of shares outstanding of the Registrant's common stock, $0.0001 par value, as of August 12, 2015, was 50,220,000.

 

1
 

 

AMENDMENT NO. 1 TO THE QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED JUNE 30, 2015

 

EXPLANATORY NOTE

 

The purpose of this Amendment No. 1 to our Quarterly Report on Form 10-Q for the period ended June 30, 2015 as filed with the Securities and Exchange Commission on August 14, 2015 is to furnish Exhibits 101 to the Form 10-Q.

 

No changes have been made to the Quarterly Report other than the furnishing of Exhibit 101.INS, 101.SCH, 101.CAL, 101.DEF, 101.LAB and 101.PRE described above. This Amendment No. 1 to Form 10-Q does not reflect subsequent events occurring after the original filing date of the Form 10-Q or modify or update in any way disclosures made in the Form 10-Q, as amended.

 

In addition, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as a result of this Amended Report, the certifications pursuant to Section 302 and Section 906 of the Sarbanes-Oxley Act of 2002, filed and furnished, respectively as exhibits to the Original Report have been re-executed and re-filed as of the date of this Amended Report and are included as exhibits hereto.

 

2
 

 

ITEM 6.  EXHIBITS

 

The following exhibits are included herein:

 Exhibit Number      Name of Exhibit
   
31.1 Certification of Chief Executive Officer, pursuant to Rule 13a-14(a) of the Exchange Act, as enacted by Section 302 of the Sarbanes-Oxley Act of 2002.
   
 31.2 Certification of Chief Financial Officer, pursuant to Rule 13a-14(a) of the Exchange Act, as enacted by Section 302 of the Sarbanes-Oxley Act of 2002.
   
 32.1 Certification of Chief Executive Officer and Chief Financial Officer, pursuant to 18 United States Code Section 1350, as enacted by Section 906 of the Sarbanes-Oxley Act of 2002.
   
101 XBRL

 

 

SIGNATURES

 

In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  MED-CANNABIS PHARMA, INC.
   
   
  By:     /s/ Gracie Moreno
                   Gracie Moreno
                   President, Chief Executive Officer,
                   Principal Executive Officer, and Director
   
 

             

 

By:    /s/ Garrett Vogel

                 Chief Financial Officer, Principal Accounting Officer,
                 Treasurer and Secretary

 

 

3